US Tech 100

19,181.60

-0.43%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Crism Therapeutics Corporation (CRTX)
Crism Therapeutics Corporation (CRTX) News

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRTX

1

Date	Time	Source	Headline	Symbol	Company
06/03/2024	9:25AM	RNS Regulatory News	Crism Therapeutics Corporation Director Dealing	LSE:CRTX	Crism Therapeutics Corporation
05/31/2024	3:58PM	Alliance News	IN BRIEF: Crism has first day of trade on AIM after name change, buy	LSE:CRTX	Crism Therapeutics Corporation
05/31/2024	1:00AM	RNS Regulatory News	Crism Therapeutics Corporation Admission to Trading and First Day of Dealings	LSE:CRTX	Crism Therapeutics Corporation
12/18/2009	12:45PM	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
11/20/2009	2:40PM	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
11/16/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
11/13/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
11/04/2009	6:00AM	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
10/21/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
09/03/2009	7:01AM	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
09/03/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
07/20/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
07/15/2009	6:04PM	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
07/08/2009	3:15PM	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX
06/12/2009	3:35PM	Dow Jones News	UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
06/12/2009	2:28PM	Dow Jones News	FDA: Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
05/19/2009	3:01PM	PR Newswire (US)	Cornerstone Therapeutics Announces Management Change	NASDAQ:CRTX
05/07/2009	6:01AM	PR Newswire (US)	Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	NASDAQ:CRTX
05/07/2009	6:00AM	PR Newswire (US)	Cornerstone Therapeutics Reports First Quarter 2009 Financial Results	NASDAQ:CRTX
04/27/2009	7:00AM	PR Newswire (US)	Cornerstone Therapeutics to Host First Quarter 2009 Conference Call	NASDAQ:CRTX
01/13/2009	4:33PM	Dow Jones News	UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
01/13/2009	2:34PM	Dow Jones News	FDA: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
11/05/2008	7:00AM	PR Newswire (US)	Cornerstone Therapeutics Announces New Board of Directors	NASDAQ:CRTX
08/01/2006	9:00AM	PR Newswire (US)	Critical Therapeutics Files Controlled Release Formulation of Zileuton	NASDAQ:CRTX